The trial leverages Calidi’s innovative virotherapy platform, offering new hope for combating this aggressive form of brain cancer.
The amended IND application moves NurOwn® closer to initiation of the pivotal Phase 3b clinical trial for ALS patients.
Joseph Spine Institute launches its Center for Regenerative Spine Medicine in Tampa, offering minimally invasive stem cell therapies for chronic spinal conditions.
Cellino has successfully manufactured and delivered patient-specific autologous induced pluripotent stem cell (iPSC) lines from four donors to Matricelf for spinal cord injury treatment.
Traumatic brain injury (TBI) occurs when trauma disrupts normal brain functions, potentially causing severe physical, cognitive, and emotional impairments. Researchers are exploring stem cells as a possible treatment because these cells might...
The National Stem Cell Foundation (NSCF) has received a $3.1 million grant from NASA to further its research on neurodegenerative diseases aboard the International Space Station (ISS). This funding will support additional...
MIT researchers have developed a new method to convert skin cells directly into neurons, bypassing the pluripotent stem cell stage in iPSC development. This technique, demonstrated in mouse cells, could potentially lead...
In March this year, a ScienceDaily article reported that Mass General is pioneering a Phase 1 clinical trial advancing stem cell therapies for Parkinson's disease. The trial involves reprogramming patients' own stem...
Phase III exPDite-2 trial follows completion and discussion of Phase I trial data with US FDA under Regenerative Medicine Advanced Therapy (RMAT) designation exPDite-2 is a randomized, sham surgery-controlled double-blind trial assessing...
Link to study, found in the journal named Reports, dated 2024. The problem? Neuropathy of the lower leg caused by tarsal tunnel syndrome Symptoms include Sharp shooting pain Pins/needles Electric shock/burning sensations...
